Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?-Reference-Cited by-同舟云学术

Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?

Published:2018-03-26 Issue:3 Volume:16 Page:269-275
ISSN:1570-1611
Container-title:Current Vascular Pharmacology
language:en
Short-container-title:CVP

Author:

Paschos Paschalis¹,Athyros Vasilios G.²,Tsimperidis Achilleas¹,Katsoula Anastasia¹,Grammatikos Nikolaos¹,Giouleme Olga¹

Affiliation:

1. Department of Internal Medicine, Gastroenterology and Hepatology Division of the Second Propedeutic, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece

2. Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece

Publisher

Bentham Science Publishers Ltd.

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NLRP3 inflammasome in hepatic diseases: A pharmacological target;Biochemical Pharmacology;2023-11

2. Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases;Biomolecules;2023-10-13

3. Higher ratio of serum uric acid to serum creatinine (SUA/SCr) increases the risk of metabolic unhealthy phenotype;Nutrition, Metabolism and Cardiovascular Diseases;2023-10

4. Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?;Biomedicines;2023-09-05

5. Altered insulin secretion dynamics relate to oxidative stress and inflammasome activation in children with obesity and insulin resistance;Journal of Translational Medicine;2023-08-20